MC
DXCM icon

Maverick Capital’s DexCom DXCM Stock Holding History

Maverick Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,664
Closed -$1.89M – 266
2024
Q2 		$1.89M Buy
+16,664
New +$2.11M 0.04% 112
2024
Q1 		– Sell
-4,876
Closed -$605K – 449
2023
Q4 		$605K Sell
4,876
-6,885
-59% -$703K 0.01% 170
2023
Q3 		$1.1M Buy
+11,761
New +$1.33M 0.02% 117
2021
Q3 		– Sell
-844
Closed -$90K – 683
2021
Q2 		$90K Sell
844
-10,912
-93% -$1.05M ﹤0.01% 573
2021
Q1 		$1.06M Buy
11,756
+10,708
+1,022% +$1.01M 0.01% 240
2020
Q4 		$97K Sell
1,048
-400
-28% -$35.7K ﹤0.01% 590
2020
Q3 		$149K Buy
+1,448
New +$151K ﹤0.01% 506

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Maverick Capital's DXCM Position: Q3 2024 in Review

Maverick Capital sold out of DexCom (DXCM) in Q3 2024, closing a stake of 16,664 shares — an estimated $1.89M sold.

Maverick Capital first reported a position in DXCM in Q3 2020 and held it in 7 quarters. The position peaked at $1.89M in Q2 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Maverick Capital reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Maverick Capital sold 16,664 DexCom shares in Q3 2024, an estimated $1.89M.
  • Maverick Capital first reported a position in DexCom in Q3 2020 and held it in 7 quarters.
  • Maverick Capital's DexCom position peaked at $1.89M in Q2 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Maverick Capital's 13F filing for Q3 2024, filed 14 Nov 2024.